This research focused on the investigation of the CD56− and CD56+ T cell subsets in the context of their differentiation and activation, including both classical markers of T cell differentiation and expression of activating and inhibitory NK cell receptors in samples from severe and moderate COVID-19 patients (32 and 28, respectively). The gene discussed is NCAM1; the disease is COVID-19.